8-K current report · filed Nov 18, 2026

Quantum-Si Inc (QSI) 8-K Current Report: November 18, 2026

Item 7.01Item EX-99.1QSI overview

Short answer

Quantum-Si Inc (QSI) filed an 8-K current report with the SEC on November 18, 2026 reporting Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Proteus development program detected all 20 naturally occurring amino acids.

Quantum-Si Inc 8-K event analysis

AI summary of each reported item and its exhibits

Item 7.01 · Regulation FD Disclosure

  • Proteus development program detected all 20 naturally occurring amino acids
  • Technical milestone supports Quantum-Si’s progress toward broader protein sequencing capabilities
  • Commercial readiness, timing and financial impact remain dependent on further development and validation

Item EX-99.1 · Exhibit EX-99.1

  • Proteus demonstrated single-molecule detection of all 20 amino acids, achieving QSI’s year-end 2026 goal ahead of schedule
  • Technical milestone establishes complete amino acid detection as a potential benchmark for protein sequencing
  • Reference-free protein identification and expanded proteoform analysis could broaden Proteus’s addressable market
  • QSI is incorporating 20-amino-acid detection into a developmental sequencing kit, with commercial launch still dependent on validation and manufacturing readiness

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Quantum-Si Inc 8-K filings

Get the next QSI 8-K as it lands

Follow QSI for push alerts, or ask the research agent what this filing means.